Establishment of a robust & safe stem cell therapy
We aim to achieve safe, economical, and practical autologous cell transplantation therapy using induced pluripotent stem cell (iPSC) technology. We use our extensive experiences in pluripotent
stem cell technology, genomics, microscopy, and neuroscience with solutions to the current technical challenges of stem cell transplantation therapy.
01
Robust and safe
iPSC bank
Establishing of robust and safe iPSC bank with highly qualified clinical-grade iPSC ready to be utilized for cell therapy applications.
02
iPSC manufacturing
pipelines
Developing comprehensive iPSC manufacturing pipelines, ensuring the safety and functionality of cell
products for cell transplantation therapy.
03
Protocols for
cell transplantation
Upgrading protocols for cell transplantation with chemical and molecular reagents that enhance the successful functional integration into the destined tissues.
04
Personalized
platform
Developing a personalized platform to screen optimal treatments using patient-derived iPSC models,
including 3D organoid systems.
